Clinical trial · Observational
Patient-Centered Acupuncture for Pain (PCAP)
Patient-Centered Integration of Acupuncture to Decrease Pain for Cancer Survivors
NCT02152020CI-TRIAL-00016616completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to find out if acupuncture can improve the management of pain in cancer patients when used as part of a treatment plan that includes conventional pain medications. The investigators will enroll 36 cancer patients at Abramson Cancer Center and Penn Cancer Network sites. Participants will be enrolled in either the Conventional Pain Management group or Integrative Pain Management group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivors | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cancer survivors
- interventionNames
- Behavioral: Survey
Primary outcomes (1)
- measure
- Number of Adverse Events
- timeFrame
- 12 weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Women or men age 18 years or older * Primary diagnosis of cancer with history of stage I, II, or III cancer * Finished primary cancer treatments (surgery, chemotherapy, radiotherapy) * Have a Karnofsky score of 60 or greater * Can understand written English * Have worst pain rated at least 4 or greater on an 11-point (0-10) numerical rating scale in the preceding week * Have been taking pain medications daily * Have had at least 15 days with pain in the preceding 30 days. Exclusion Criteria: * Women or men with metastatic (stage IV) cancer * Unstable and progressive medical conditions as judged by the PIs or designated research nurse at the community hospitals (e.g., progressive cancer, uncontrolled heart failure) that may require hospitalization in the next 12 weeks * Planned surgical procedures in the next 12 weeks * Patients currently in a pain crisis as judged by the PI or designated research nurse that may warrant acute titration of medications or hospitalization * Women who are pregnant or breastfeeding * Unwillingness to adhere to study related procedures.
References
Publications (0)
Data not yet available
No reference posted for this study.